IPO Key Dates

Anchor Investor Subscription  
IPO opens on 29 Sept. 2025
IPO Closes on 1 Octo 2025
Allotment on 3 Octo. 2025
Credit of shares on 6 Octo. 2025
Tentative Listing on 7 Octo.2025
Registered office in..
Mumbai Maharastra
Email-  investors@vijaypdceutical.com
Lead Manager of the IPO
Smart Horizon Capital Advisors Pvt ltd
Registrar to the IPO
Kfin Technologies ltd

Business:

Incorporated in October 1971, Vijaypd Ceutical Limited is engaged in distribution of pharmaceutical products and consumer goods, with a wide service range as representatives, dealers, agents, stockists, suppliers, traders, and packers. The company caters to pharmaceuticals, wellness and FMCG markets, covering medicines, vitamins, hormones, enzymes, ayurvedic products, cosmetics, diagnostics, baby care, sanitizers and personal care. As on March 31, 2025, it serves over 2,109 pharmacies, clinics and nursing homes across 20 locations in four districts. Its strong distribution network connects with more than 170 healthcare manufacturers and gives access to over 19,000 SKUs. Backed by FDA, FSSAI and BMC certifications, the company ensures quality and reliability in its supply chain.

IPO Details

 
IPO opens on  29 September 2025
IPO closes on  1 October 2025
Issue Type Book Built Issue IPO
Issue Size 55,00,000 Shares /
Rs 19.25 Crore
* Fresh Issue
* Offer for Sale –
Market Maker Portion 2,84,000 Shares
Net offer to Public 52,16,000 Shares
Rs. 18.26 Crores
Face Value per share Rs. 10
Price Band Rs. 35
Employee discount  Rs. 0 per share
Retail Lot Size  4000 Shares
Listing will at  NSE SME

How shares are being offered

Investor Category Shares Offered
Market Maker  5.16%
NII (HNI)  47.42%
Retail Shares Offered 47.42%
Total Shares  100.00%
How shares can be applied?
Application Shares Amount
Retail (Min) 8,000 2,80,000
Retail (Max) 8,000 2,80,000
HNI (Min) 12,000 4,20,000

 

The Promoters’ Holding

The promoters hold 78.30% of the pre-IPO capital

The Objects of the IPO

The Company proposes to utilize the Net Proceeds from Issue towards funding the following objects

Objects of the Issue ₹ in crores
Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra 10.83
Repayment/prepayment of all or certain of the borrowings availed of by the Company 5.1
General corporate purposes 0.7

Financials Snapshot

Period Ended 31-Mar-25 31-Mar-24 31-Mar-23
Assets 57.15 33.27 32.87
Total Income 107.59 54.34 50.59
Profit After Tax 4.8 1.65 0.18
EBITDA 8.59 4.87 1.32
NET Worth 32.17 1 4.93
Reserves and Surplus 18.14    
Total Borrowing 21.77 30.04 25.56
Amount in ₹ Crore

 

Peer Comparison:

Key Financial Indicators

KPI Values
ROE 28.91%
ROCE 17.30%
Debt/Equity 0.68
RoNW 14.91%
PAT Margin 4.49%
EBITDA Margin 8.04%

IPO REcommendation/Concise Review-

So-So

Quicklinks

# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

Leave a Reply

Your email address will not be published. Required fields are marked *